Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUCY2C CAR-T in Advanced Digestive Tract Tumors
NCT04652219Phase 1Completed
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GUCY2C CAR-T cells in colorectal cancer (CRC), pancreatic cancer (PC) and gastric cancer (GC). Primary endpoint: Number of participants with CAR-T treatment-related adverse events at 24 months. Started Oct 2020; status: completed.
02
Drugs
GUCY2C CAR-T cells
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)gastric cancer (GC)
Beyond the preview
Go deeper on NCT04652219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652219.